SETD7 and cancer: With more in-vitro and in-vivo experimental evidences, the SET7/9 inhibitors identified so far may serve as chemical probe tool to interrogate the biological function of SET7/9, or more importantly, as potential chemical agents for pharmacological intervention in clinical treatment of cancer.